A carregar...
Early inhibitors of human cytomegalovirus: State-of-art and therapeutic perspectives
Human cytomegalovirus (HCMV) infection is associated with severe morbidity and mortality in immunocompromised individuals, mainly transplant recipients and AIDS patients, and is the most frequent cause of congenital malformations in newborn children. To date, few drugs are licensed for the treatment...
Na minha lista:
| Publicado no: | Pharmacol Ther |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Elsevier Inc.
2011
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7112563/ https://ncbi.nlm.nih.gov/pubmed/21570424 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.pharmthera.2011.04.007 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|